Hypotension Clinical Trial
Official title:
SHoC-ED: Sonography in Hypotension and Cardiac Arrest in the Emergency Department.
This study is designed to determine if there is any relationship between performing an abdominal ultrasound on patients who present with hypotension and their clinical outcomes (as measured by 7, 30 day and discharge mortality).
STRUCTURED RESEARCH ABSTRACT
Introduction
Patients who present to the ED (emergency department) with undifferentiated, non-trauma
associated hypotension are often affected by conditions with a prognosis largely dependent on
the time taken from presentation to correct diagnosis and intervention. The ACES protocol
(Abdominal and Cardiothoracic Evaluation with Sonography in Shock) provides a rapid focused
ultrasound protocol for making or refining diagnoses in patients who present to the ED with
this type of hypotension. This will be the first study to compare the clinical outcomes of
patients who are assessed with the ACES protocol as part of their initial workup to those of
patients who are assessed without any intervention by ultrasound. The goal of this study is
to determine if ACES enhances the patient's clinical outcomes, as measured by: 1) Time to
restoration (or improvement) of CVS (cardiovascular system) parameters, 2) Rate of
normalization of acid-base balance, as well as venous lactate 3) Significant change in
diagnosis or recommended intervention 4) Frequency of unexpected diagnosis, and 5) Patient 7
and 30-day, and discharge mortality rate.
Methods
SHoC-ED 1 is a stratified randomized control trial that will run in multiple centers across
Canada and internationally. The data will be stratified in that each center involved will
recruit equal amounts of control and intervention patients. While different centers will
recruit different numbers of participants, each individual center will recruit near-equal
amounts for each arm of the study.
ED nurses will identify potential candidates for the SHoC-ED 1 study, and flag their charts
to notify the attending physician. ED Physicians trained on the ACES protocol will then
proceed to review the exclusion criteria (part of patient inclusion sheet/patient flag) and
where appropriate, obtain consent. After these are completed, the physician will retrieve an
envelope that contains the already randomized forms appropriate for whichever arm the patient
has been randomized to. This randomization will place patients in either the ACES group (to
be referred to as Group 1), or the control group (to be referred to as Group 2). Physicians
following the group 1 protocol will perform their normal initial assessment and then do ACES,
recording their data after each step. Physicians in group 2 will simply record their data
after the initial assessment. Both groups of physicians will then record their impressions at
60 minutes as this will enable this project to determine how changes in diagnoses are
affected by non-ultrasound factors in the first hour a patient is in the ED. These diagnoses
will then be compared against the "final" diagnoses made during the patient's admission.
Exclusion criteria for this study include the following: A) necessity of CPR or other
advanced life support interventions before enrollment, B) History of significant trauma in
past 24 hours, C) A 12 lead ECG diagnostic of STEMI, D) Mechanism of shock is clear (i.e. not
undifferentiated shock), E) previously known diagnosis from other hospital, F) previously
confirmed pregnancy, G) vagal episode H) Low blood pressure is not actually pathologic
hypotension, but instead a normal variant or some other phenomenon.
To ensure that scans are being performed properly and consistently at all sites included in
this study local principal investigators will be responsible for ensuring appropriate
training and monitoring of standards for the physicians at their center performing ACES.
The data collected from both Group 1 and Group 2 will then be compared against each other,
and follow-up will be conducted to ascertain if the early intervention with ACES had any
implications on long-term outcomes.
Results
Given that much of the data interpreted will be comparing numerical values from different
strata (Example: Time taken to operating theatre compared between Group 1 and 2), ANOVA
testing will be used. The results of the ANOVA test will be used to determine if there is a
significant difference in outcome, as measured by 1) Time to restoration (or improvement) of
CVS parameters, and 2) Rate of normalization of acid-base balance (using either venous or
arterial blood gas), and blood lactate.
For categorical data (Example: Mortality rate between groups), chi-square analyses will be
performed to determine statistically significant increase in clinical outcome. This will be
done for:
- Significant changes in diagnosis/recommendations in intervention change, and
- Frequency of unexpected diagnosis.
Conclusion
This SRCT (stratified randomized control trial) will determine whether the ACES protocol
leads to improved clinical outcomes in patients who present to the ED with undifferentiated,
non-trauma associated shock. It will compare intervention with the ACES protocol to
intervention with no ultrasound at all.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
Active, not recruiting |
NCT02016599 -
Effects of Transitional Circulation in ELBW Infants
|
||
Recruiting |
NCT05836610 -
Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
|
Phase 4 | |
Suspended |
NCT02315937 -
Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography'
|
N/A | |
Completed |
NCT03215797 -
Phenylephrine or Norepinephrine for a Better Hemodynamic Stability
|
Phase 3 | |
Completed |
NCT02907931 -
Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status
|
N/A | |
Recruiting |
NCT02532270 -
Detecting Hypotension By Continuous Non-invasive Arterial Pressure Monitoring
|
N/A | |
Completed |
NCT02802683 -
Hemodynamic Impact of Hyperbaric Versus Isobaric for Spinal Anesthesia During Cesarean Delivery
|
Phase 4 | |
Completed |
NCT02437799 -
Dicrotic Notch and Hypotension at Caesarean Under Spinal Anaesthesia
|
N/A | |
Completed |
NCT01930227 -
Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hypotension After Spinal Anesthesia in Parturients
|
N/A | |
Not yet recruiting |
NCT01941472 -
Transcutaneous pO2, Transcutaneous pCO2 and Central Venous pO2 Variations to Predict Fluid Responsiveness
|
N/A | |
Completed |
NCT02146898 -
The Severity Of Hypotension Comparing Three Positions During Spinal Anesthesia For Cesarean Delivery
|
N/A | |
Recruiting |
NCT01434251 -
Treatment of Hypotension of Prematurity (TOHOP)
|
N/A | |
Withdrawn |
NCT01183741 -
Accuracy of Non-Invasive Blood Pressure Measurement in Adults
|
Phase 3 | |
Completed |
NCT01592669 -
Passive Leg Raising Attenuates and Delays Tourniquet Deflation-induced Hypotension and Tachycardia
|
N/A | |
Completed |
NCT00991627 -
Different Approaches to Maternal Hypotension During Cesarean Section
|
Phase 4 | |
Withdrawn |
NCT00750516 -
Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
|
||
Completed |
NCT00115726 -
Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure
|
Phase 4 | |
Recruiting |
NCT05513066 -
Management Arterial Hypotension During Planned Caesarean Section, Intravenous Ephedrine/Phenylephrine Mixture Versus Intravenous Baby Noradrenaline
|
||
Completed |
NCT04089644 -
Manual vs Closed-loop Control of Mean Arterial Pressure
|
N/A |